Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL459799 | 0.95 | KCNH2 (0.35) | KCNH2CA12CA1CA9PYCR1 | |
| SCHEMBL17017116 | 0.92 | KCNH2 (0.34) | KCNH2CA12CA1CA9PYCR1 | |
| SCHEMBL16965227 | 0.90 | DNM1 (0.44) | KCNH2 | |
| SCHEMBL8519897 | 0.85 | DNM1 (0.44) | KCNH2 | |
| SCHEMBL30692301 | 0.85 | DNM1 (0.44) | KCNH2 | |
| SCHEMBL30156804 | 0.85 | DNM1 (0.44) | KCNH2 | |
| SCHEMBL24693238 | 0.83 | EPHX1 (0.33) | KCNH2 | |
| SCHEMBL935039 | 0.80 | PYCR1 (0.38) | CA12CA9PYCR1CA2 | |
| Oxalic Acid SCHEMBL7356011 | 0.80 | KCNH2 (0.41) | KCNH2CA12CA1CA9 | |
| SCHEMBL413078 | 0.78 | HMGCR (0.43) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100168441-A1 | PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168441-A1 | PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE | MYB, KCNH2, INTS9 | KCNH2 2/4885CA12 637/4885CA1 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.